These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 710708)

  • 1. Complex kinetic data obtained with neutral proteinase and its inhibitor present in tumour-cell preparations.
    Steven F; Podrazký V; Itzhaki S
    Biochem Soc Trans; 1978; 6(4):759-60. PubMed ID: 710708
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of a trypsin-dependent neutral protease and its inhibitor found in tumour cells. Analysis of complex kinetic data involved in a thiol-disulphide exchange mechanism.
    Steven FS; Podrazký V; Itzhaki S
    Biochim Biophys Acta; 1978 May; 524(1):170-82. PubMed ID: 656442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental analysis: the application to quantitation of both enzyme activity and inhibitory activity in complex subcellular fractions.
    Steven FS; Podrazký V; Foster RW
    Anal Biochem; 1978 Oct; 90(1):183-91. PubMed ID: 727463
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteolytic activity associated with tumour growth and metastasis. Influence of trypsin inhibitor (soya bean) on Ehrlich ascites tumour growth [proceedings].
    Verloes R; Kanarek L
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1119-20. PubMed ID: 66028
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition kinetics of a trypsin-like neutral proteinase on the surface of Ehrlich ascites-tumour cells.
    Steven FS; Griffin MM; Itzhaki S
    Biochem Soc Trans; 1981 Feb; 9(1):146-7. PubMed ID: 7011870
    [No Abstract]   [Full Text] [Related]  

  • 6. A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Br J Cancer; 1980 Nov; 42(5):712-21. PubMed ID: 6257267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of Ca2+-activated protease specific for the intermediate-sized filament protein vimentin in Ehrlich-ascites-tumour cells.
    Nelson WJ; Traub P
    Eur J Biochem; 1981 May; 116(1):51-7. PubMed ID: 7018903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and further characterization of the Ca2+-activated proteinase specific for the intermediate filament proteins vimentin and desmin.
    Nelson WJ; Traub P
    J Biol Chem; 1982 May; 257(10):5544-53. PubMed ID: 7040367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversible thiol-disulphide exchange of trypsin and chymotrypsinogen with a tumour-derived inhibitor. Kinetic data obtained with fluorescein-labelled polymeric collagen fibrils and casein as substrates.
    Steven FS; Podrazký V
    Biochim Biophys Acta; 1979 May; 568(1):49-58. PubMed ID: 444546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of protease in mast cell granules.
    Okuno-Kaneda S; Saito T; Kawasaki Y; Ichikawa A; Tomita K
    Biochem Pharmacol; 1980 Jun; 29(12):1715-22. PubMed ID: 6996680
    [No Abstract]   [Full Text] [Related]  

  • 11. A protease-like activity associated with malignant cells.
    Schnebli HP
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1194-7. PubMed ID: 5055041
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
    Steven FS; Griffin MM; Itzhaki GS; Al-Habib A
    Biochim Biophys Acta; 1981 Aug; 660(2):333-40. PubMed ID: 6269636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the presence of a trypsin inhibitor within rabbit and mouse tumour cells.
    Steven FS; Podrazky V; Itzhaki S
    Biochim Biophys Acta; 1977 Jul; 483(1):211-4. PubMed ID: 880306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for metal inhibition of tumour membrane-bound neutral protease and the control of tumour-induced target cell cytolysis.
    Steven FS; Hulley TP; Griffin MM; Itzhaki S
    Br J Cancer; 1982 Dec; 46(6):934-9. PubMed ID: 6185130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutral proteases of the mast cell.
    Lagunoff D
    Kroc Found Ser; 1981; 14():89-101. PubMed ID: 7031197
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for inhibitors of the cell surface protease guanidinobenzoatase.
    Steven FS; Griffin MM; Wong TL; Itzhaki S
    J Enzyme Inhib; 1986; 1(2):127-37. PubMed ID: 3508910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular distribution of neutral proteinases and inhibitors in pig leucocytes. Isolation of two inhibitors of neutral proteinases.
    Kopitar M; Lebez D
    Eur J Biochem; 1975 Aug; 56(2):571-81. PubMed ID: 240715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous proteolytic activity of chromatin.
    Anachkova B; Russev G
    Acta Biol Med Ger; 1977; 36(11-12):1945-50. PubMed ID: 616741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular proteinases and their inhibitors.
    Prog Clin Biol Res; 1985; 180():3-9. PubMed ID: 3898105
    [No Abstract]   [Full Text] [Related]  

  • 20. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells.
    Le Trong H; Neurath H; Woodbury RG
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):364-7. PubMed ID: 3540962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.